Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest.
about
Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competenceCan anti-Mullerian hormone replace ultrasonographic evaluation in polycystic ovary syndrome? A review of current progressRole of Anti-Müllerian Hormone in pathophysiology, diagnosis and treatment of Polycystic Ovary Syndrome: a reviewAdvanced Glycation End Products: Link between Diet and Ovulatory Dysfunction in PCOS?Value of ultrasonography in the diagnosis of polycystic ovary syndrome - literature reviewIs Anti-Müllerian Hormone Associated With Fecundability? Findings From the EAGeR TrialComparability of antimüllerian hormone levels among commercially available immunoassaysScientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome.Prenatal exposures and anti-Mullerian hormone in female adolescents: the Avon Longitudinal Study of Parents and ChildrenAnti-Mullerian hormone may be a useful adjunct in the diagnosis of polycystic ovary syndrome in nonobese adolescents.Characterization of functionally typical and atypical types of polycystic ovary syndrome.Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guidelineSerum anti-mullerian hormone concentrations are elevated in oligomenorrheic girls without evidence of hyperandrogenismGenetics of polycystic ovary syndromeEffect of glucocorticoid-induced insulin resistance on follicle development and ovulation.Assay reproducibility and within-person variation of Müllerian inhibiting substance.Biological variability in serum anti-Müllerian hormone throughout the menstrual cycle in ovulatory and sporadic anovulatory cycles in eumenorrheic women.Differentiation between polycystic ovary syndrome and polycystic ovarian morphology by means of an anti-Müllerian hormone cutoff value.Serum luteinizing hormone level and luteinizing hormone/follicle-stimulating hormone ratio but not serum anti-Müllerian hormone level is related to ovarian volume in Korean women with polycystic ovary syndromeRegulation of anti-Müllerian hormone production in the cow: a multiscale study at endocrine, ovarian, follicular, and granulosa cell levels.Anti-Müllerian hormone: correlation with testosterone and oligo- or amenorrhoea in female adolescence in a population-based cohort study.The role of anti-Müllerian hormone in female fertility and infertility - an overview.Comparing serum basal and follicular fluid levels of anti-Müllerian hormone as a predictor of in vitro fertilization outcomes in patients with and without polycystic ovary syndrome.Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society.The physiology and clinical utility of anti-Mullerian hormone in women.Novel role for anti-Müllerian hormone in the regulation of GnRH neuron excitability and hormone secretionOvarian Features after 2 Weeks, 3 Weeks and 4 Weeks Transdermal Testosterone Gel Treatment and Their Associated Effect on IVF Outcomes in Poor Responders.Lack of Serum anti-Mullerian hormone responses after recombinant human chorionic gonadotropin stimulation in women with polycystic ovary syndrome.The circadian variation in Anti-Müllerian hormone in patients with polycystic ovary syndrome differs significantly from normally ovulating women.Intraovarian control of early folliculogenesisPolycystic ovary syndrome: current status and future perspectiveFirst assessment of menstrual cycle function and reproductive endocrine status in Samoan women.Serum antimüllerian hormone in healthy premenopausal women.Serum anti-Müllerian hormone as a predictive marker of polycystic ovarian syndrome.Anti-mullerian hormon level and polycystic ovarian syndrome diagnosisWhat is the value of anti-Müllerian hormone in predicting the response to ovarian stimulation with GnRH agonist and antagonist protocols?Gene variants associated with age at menopause are also associated with polycystic ovary syndrome, gonadotrophins and ovarian volume.Relating smoking, obesity, insulin resistance, and ovarian biomarker changes to the final menstrual period.Does AMH Reflect Follicle Number Similarly in Women with and without PCOS?
P2860
Q24629523-E5194FF9-57BC-463E-A59F-F26123C794BEQ26773554-2F9A22ED-5DCA-4107-A97B-95999C231AACQ26774060-2E9153EB-10AF-41A5-9E66-258574B852EEQ26774333-6237E418-E36F-46CE-A236-BF59061BF7ACQ26774941-641CA057-D748-4801-A6A7-209AAC0F0A4CQ28383121-38A4574E-0351-4113-9D68-C5552EAF7BF3Q28388149-694DB6E3-02AB-4ED2-A5CD-05F2B777AF21Q28390200-088358E2-6F87-41CF-84A9-1727C3576437Q28390416-507BDFE9-BAB3-4479-B4FB-07144901ECBDQ30405604-BABF7BE3-BDE9-475F-8532-D94CD7426D14Q30436274-27A6BA07-D14A-4DD6-9D30-3C0DAE8C33CCQ33569169-7A41B2E1-F8A4-409E-8002-5D875177D96AQ33587845-14D1679C-4A82-4691-8C4F-A3ECEEDD0268Q33786859-F54ACC79-EC42-4B85-9CE4-698F8FC1B9ECQ33792142-B22351F9-3ADE-4B1E-BED2-ABF6AEFB85B1Q33806350-F81B934D-6AD8-492B-BE27-44D9EAAD15B0Q33875907-2E26162E-9C13-4202-971C-D5E3AD5AFF92Q33888297-A2FC6145-0A0A-48A3-8878-EE197040B09BQ33907212-F9790C91-0953-4BEB-A352-E0C3334B2202Q33917112-E25E98C3-4624-4BE6-A282-7950B3825D11Q34149740-8D297EB4-FAA0-424E-9BDE-E633C568E868Q34181497-12524E02-4BC3-4B0E-A043-139920C704F7Q34278051-F858C96D-1BBD-46D1-9868-27B3EC20FDCDQ34363167-8774AA6D-E702-44A0-8AE3-2E09B7F88083Q34392414-4E3D0F6B-2F47-4346-AEA5-456511719170Q34398233-699D9DF5-A8E8-493A-824D-0A1561915838Q34508533-45AFB2F9-533C-4A15-8D12-B15640CD974BQ34804162-D4D6CD23-548C-4FBF-8C6B-71DED9FB3EB8Q34810982-6D9FA1E1-BA2E-47BC-8DD3-A9B2D650629AQ34983821-15B68DC1-FA2D-4AAD-B841-A6034795017DQ35024088-16B78BB6-5066-4739-A05B-BD7F5645CB94Q35124537-935995C3-4107-485A-B484-5428C2760C8EQ35169303-7A44981D-D23A-470F-B3B9-58181B71D4ABQ35185385-A9C275E0-1EB9-4071-9AEB-7894C8A421CBQ35560602-17394EB4-9D51-47B7-9998-4D74C64AFD7BQ35679407-EA1ED538-4CDB-4FCA-A858-42B02D0A7510Q35750252-25510D50-CB4D-447F-A15D-F4B43F980B45Q35755656-C8AEEB4E-11C0-48F3-AC49-EE720EF633FCQ35811703-777895A0-E503-4424-B4A6-B71823DFC9F5Q35901133-D900E9FE-2521-4793-A13C-94378DB395F1
P2860
Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Elevated serum level of anti-m ...... and to the follicular arrest.
@en
Elevated serum level of anti-m ...... and to the follicular arrest.
@nl
type
label
Elevated serum level of anti-m ...... and to the follicular arrest.
@en
Elevated serum level of anti-m ...... and to the follicular arrest.
@nl
prefLabel
Elevated serum level of anti-m ...... and to the follicular arrest.
@en
Elevated serum level of anti-m ...... and to the follicular arrest.
@nl
P2093
P356
P1476
Elevated serum level of anti-m ...... s and to the follicular arrest
@en
P2093
Christine Cortet-Rudelli
Christine Decanter
Emilie Merlen
Pascal Pigny
Sophie Jonard
Yann Robert
P304
P356
10.1210/JC.2003-030727
P407
P577
2003-12-01T00:00:00Z